Description

Ascend Biopharmaceuticals Ltd is a limited by shares Australian public company. Located at VIC 3084 since 2007-11-07 the company is, as the updated on 2012-07-17 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2006-12-11. Known company numbers for Ascend Biopharmaceuticals Ltd are as follows: ACN - 106265098, Australian Business Number - 45106265098. Ascend Biopharmaceuticals Ltd has been the company name since 2013-10-03. Their official company name changed on 2006-12-11 to Igavax Pty Ltd. The company had used this name up until 2012-07-16. This Australian public company was previously located in VIC 3084 (from 2006-12-11 to 2007-11-07).

Advertisements

Details for ABN 45106265098

Type: Australian Private Company

ABN Status

Status

From

To

Active

2006/12/11

current

Main Name

Name

From

To

Ascend Biopharmaceuticals Pty Ltd

2012/07/16

current

Igavax Pty Ltd

2006/12/11

2012/07/16

Main Location

Location

From

To

VIC 3084

2007/11/07

current

VIC 3084

2006/12/11

2007/11/07

Goods & Services Tax (GST)

Status

From

To

Registered

2006/12/11

current

Advertisements

Company Patents

Patent Application Number: 2012200183

General information:

Application date:

2012/01/12

Patent status:

Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k)

Mark type:

First (ie Primary)

Classification level:

Advanced

Classification code:

Inventive

IPC Classification assigned/Application publish date:

2012/01/17

Classification type code:

Original

Classification source code:

Human

IP Australia process information:

Source code:

PAMS

Patent classification type:

Standard

Examination request filing date:

2012/01/12

Requested examination type:

Request Full Examination

First report issue date:

2012/08/13

Examination section:

A1 PBR, Plants and Biotechnology

Expiry date:

2031/05/10

Earliest priority date:

2010/05/10

Acceptance Notice date:

2012/09/20

Sealing date:

2013/01/03

Effective patent date:

2011/05/10

OPI published in journal date:

2012/02/02

Patent in force to:

2015/05/10

Change of Ownership:

Request filed date:

2012/09/05

Name change date:

2012/09/10

Advertised date:

2012/09/20

Change reason:

Request for Assignment

Assignment validated date:

2012/08/23

Document description:

Deed of Assignment

Name type:

New

Patent Application Number: 2001263653

General information:

WIPO Application Number:

WO2001/093912

Original WIPO Application Number:

WO01/93912

PCT Application Number:

PCT/AU2001/000669

Original PCT Application Number:

PCT/AU01/00669

Mainframe Application Number:

163653

Accepted claims count:

16

International Patent Classification:

IPC Mark:

A61K 47/36

Version date of the IPC Classification record:

2006/01/01

Section code:

A - human necessities

Class code:

61 - medical or veterinary science; hygiene

Subclass code:

K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l)

Patent Application Number: 2011226992

General information:

Application date:

2011/09/06

Patent status:

Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.